IN2015DN03104A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03104A
IN2015DN03104A IN3104DEN2015A IN2015DN03104A IN 2015DN03104 A IN2015DN03104 A IN 2015DN03104A IN 3104DEN2015 A IN3104DEN2015 A IN 3104DEN2015A IN 2015DN03104 A IN2015DN03104 A IN 2015DN03104A
Authority
IN
India
Prior art keywords
extracts
relates
present
dyslipidaemia
hyperglycaemia
Prior art date
Application number
Inventor
Ezio; Bombardelli
Fabrizio; Corti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of IN2015DN03104A publication Critical patent/IN2015DN03104A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A21D2/266—Vegetable proteins from leguminous or other vegetable seeds; from press-cake or oil bearing seeds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether

Abstract

The present invention relates to extracts of deoiled seeds which are useful for the prevention and treatment of dyslipidaemia , hyperglycaemia and hypertension , metabolic syndrome and type 2 diabetes. The present invention also relates to the process for preparation of said extracts and compositions containing them. The extracts according to the invention when added to carbohydrate- based foods ,reduce the glycaemic index and postprandial absorption of glucose , and induce a modification of the lipid profile.
IN3104DEN2015 2012-10-16 2013-10-08 IN2015DN03104A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001749A ITMI20121749A1 (en) 2012-10-16 2012-10-16 HELIANTHUS ANNUUS EXTRACTS USEFUL IN THE TREATMENT OF THE METABOLIC SYNDROME AND IN THE DECREASE OF THE GLICEMIC FOOD INDEX AND PROCEDURE FOR THEIR PREPARATION AND THE COMPOSITIONS THAT CONTAIN THEM
PCT/EP2013/070928 WO2014060244A1 (en) 2012-10-16 2013-10-08 Process for obtaining caffeoylquinic acids-rich extracts from helianthus annuus

Publications (1)

Publication Number Publication Date
IN2015DN03104A true IN2015DN03104A (en) 2015-10-02

Family

ID=47425209

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3104DEN2015 IN2015DN03104A (en) 2012-10-16 2013-10-08

Country Status (15)

Country Link
US (1) US20150258155A1 (en)
EP (1) EP2908663A1 (en)
JP (1) JP2015535216A (en)
KR (1) KR20150068959A (en)
CN (1) CN104717892A (en)
AU (1) AU2013331918B2 (en)
BR (1) BR112015008075A2 (en)
CA (1) CA2888305A1 (en)
HK (1) HK1211439A1 (en)
IL (1) IL238272A0 (en)
IN (1) IN2015DN03104A (en)
IT (1) ITMI20121749A1 (en)
RU (1) RU2015113521A (en)
SG (1) SG11201502908TA (en)
WO (1) WO2014060244A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6129762B2 (en) * 2013-10-04 2017-05-17 富士フイルム株式会社 Method for producing chlorogenic acid-containing composition
EP3351117A4 (en) * 2015-09-17 2019-04-10 San-Ei Gen F.F.I., INC. Extract from seeds of plant genus helianthus, and method for producing same
CN111683671A (en) 2017-10-06 2020-09-18 嘉吉公司 Method for preparing mate tea extract composition
WO2020210161A1 (en) * 2019-04-06 2020-10-15 Cargill, Incorporated Methods for making botanical extract composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100421689C (en) * 2003-08-26 2008-10-01 上海永恒生物科技有限公司 Preparation technology of crataegus total phenolic acid portion and application
CN100382798C (en) * 2006-01-20 2008-04-23 深圳市生物谷科技有限公司 Pharmaceutical composition containing caffeoylquinic acids
PL1967198T3 (en) * 2007-03-07 2009-10-30 Indena Spa Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
CN101057674B (en) * 2007-06-13 2010-09-08 深圳市金沙江投资有限公司 Composition for preventing and curing diabetes
JP5155435B2 (en) * 2010-11-24 2013-03-06 花王株式会社 Method for producing roasted coffee bean extract
CN102000051B (en) * 2010-11-24 2011-12-21 山东省科学院生物研究所 Application of 5-caffeoylquinic acid in preparing anti-tumor drugs
CN102100720B (en) * 2011-02-15 2012-03-28 江西本草天工科技有限责任公司 Ainsliaea fragrans champ caffeoylquinic acid extracts and preparation and application thereof
CN102617667B (en) * 2012-03-05 2014-07-30 南京师范大学 Method for simultaneously preparing total caffeoylquinic acid and stevioside by taking stevia as raw material

Also Published As

Publication number Publication date
CN104717892A (en) 2015-06-17
AU2013331918B2 (en) 2017-01-12
CA2888305A1 (en) 2014-04-24
WO2014060244A1 (en) 2014-04-24
AU2013331918A1 (en) 2015-05-07
BR112015008075A2 (en) 2017-07-04
ITMI20121749A1 (en) 2014-04-17
EP2908663A1 (en) 2015-08-26
SG11201502908TA (en) 2015-06-29
IL238272A0 (en) 2015-06-30
KR20150068959A (en) 2015-06-22
JP2015535216A (en) 2015-12-10
RU2015113521A (en) 2016-12-10
US20150258155A1 (en) 2015-09-17
HK1211439A1 (en) 2016-05-27

Similar Documents

Publication Publication Date Title
PH12015501291B1 (en) Functionalized exendin-4 derivatives
BR112015023484A2 (en) carbohydrate composition, product and process to prepare a carbohydrate composition
CL2015000851A1 (en) Compounds derived from pyridine, gdf-8 inhibitors; pharmaceutical composition; method to treat disorders or diseases such as muscular dystrophy, osteoporosis, obesity, type 2 diabetes, impaired glucose tolerance, among others.
WO2013186240A3 (en) Exendin-4 peptide analogues
MY188344A (en) Extract formulations of rhodamnia cinerea and uses thereof
BR112015002139A2 (en) sweetening compositions containing rebaudioside b
BR112015002366A2 (en) grease, vegetable paste and hard raw material composition.
BR112013012617A2 (en) use of glycosidase in the preparation of a milk product
NZ707859A (en) Inhibitors of sodium glucose cotransporter 1
MX349254B (en) Compounds for treatment of metabolic syndrome.
TR201901262T4 (en) Compositions Containing (2S, 3R, 4R, 5S, 6R) -2- (4-Chloro-3- (4-Ethoxybenzyl) Phenyl) -6- (Methylthio) Tetrahydro-2H-Pyran-3,4,5-Triol
BR112014013282A2 (en) cocoa food
NZ700067A (en) Dietary supplement
IN2015DN03104A (en)
BR112017013004A2 (en) fried product obtained from a composition for a fried product, use of a microalgae flour as a fat substitute and method of preparing a fried product
WO2016068453A8 (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
PH12015501099A1 (en) Synbiotic composition and use thereof
PH12017500795B1 (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
BR112013018954A2 (en) use of at least one co-product from the vegetable oil refining industry to obtain a total unsaponifiable purified vegetable oil.
WO2013139488A3 (en) Sugar-reduced frosted cereal product
WO2013071400A8 (en) Apocynin-lipoic acid conjugates and uses thereof cross-reference to related applications
EP2841077A4 (en) Dietary fiber compositions for the treatment of metabolic disease
WO2008064302A3 (en) Methods for reducing circulating glucose levels
BR112013026868A2 (en) intermediate for caspofungin synthesis and method for its preparation
MX349587B (en) Cynara scolymus extracts for the treatment of dyslipidaemia.